BioSpace News Archive

Concord Medical Schedules 2022 Annual Meeting of Shareholders

Concord Medical Services Holdings Limited today announced that it will hold its 2022 annual general meeting of shareholders (the “Meeting”) on December 30, 2022, at 10:00 a.m. (Beijing Time).

November 25, 2022
·
2 min read
Business

Can-Fite Reports Third Quarter 2022 Financial Results & Provides Clinical Update

Can-Fite BioPharma Ltd. today announced financial results for the quarter ended September 30, 2022.

November 25, 2022
·
12 min read
Business

Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results

Mednow Inc. is pleased to announce the Company will be hosting its quarterly conference call on Tuesday November 29, 2022 at 8:30am EST.

November 25, 2022
·
1 min read
Business

Captor Therapeutics Reports Q3 2022 Results and Provides Business UpdateLead assets approaching the clinic and new significant drug discovery collaboration signed with Ono Pharmaceutical

Captor Therapeutics S.A. reports its financial results for the third quarter of 2022 and provides a business update.

November 25, 2022
·
4 min read
Deals

Liminal BioSciences Announces Holding of Special Meeting of Shareholders

Liminal BioSciences Inc. announced that it will be holding a virtual special meeting of shareholders on January 20th, 2023.

November 25, 2022
·
7 min read
Neurophet, to participate in the Radiological Society of North America RSNA 2022

Neurophet, an artificial intelligence (AI) solution company for brain disease, announced on the 25th that Neurophet would participate in the Radiological Society of North America 2022 (RSNA 2022).

November 25, 2022
·
3 min read
New study on deep learning technology for improving MRI image quality published in European Radiology

SwiftMR™, an AI-powered MRI reconstruction solution from AIRS Medical proved its performance for enhancing the image quality of 3D high-resolution MRI.

November 25, 2022
·
2 min read
Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

Oncopeptides AB announced that the company has entered into a renewed unsecured loan facility agreement with the European Investment Bank, granting access to a conditional loan facility of up to €30 million.

November 25, 2022
·
5 min read
BioMidwest

Lifecore Biomedical Raises Capital for Growth with Existing Stockholder

Lifecore Biomedical, Inc. announced the closing of a $5 million private placement of its common stock with affiliates of Wynnefield Capital, Inc., a longtime stockholder of the Company, at $7.97 per share.

November 25, 2022
·
3 min read
Genetown

Hologic to Showcase Portfolio of Comprehensive Breast and Skeletal Health Solutions at RSNA 2022

Hologic, Inc. (Nasdaq: HOLX) will exhibit its extensive portfolio of breast and skeletal health products at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 27 to Dec. 1.

November 25, 2022
·
6 min read